← Insider buys
PCRX

Pacira BioSciences, Inc. · Healthcare

Director Andreas Wicki sold $12.4M of Pacira BioSciences, Inc.

Sold$12,384,678
$71.92Price
172,191Shares
−25%Stake

What PCRX did after the filing

Prices for PCRX after this filing aren't in yet.

Traded Tue, Mar 9. Filed Thu, Mar 11, 4:37 PM ET, after the close. Not investment advice.